NEWS – Sally Amanuel appointed as the new President of PrimeVigilance
Published 29 July 2021.
PrimeVigilance is delighted to welcome Sally Amanuel as the new President of PrimeVigilance Ltd.
Sally has a proven track record in driving transformational changes and delivering business results in highly regulated environments across Pharma, Biotech, and CRO industries. She is a people-first leader, with an unwavering commitment to quality and innovation. She is adept at building diverse and inclusive, high-performing teams. Her strength of leadership places PrimeVigilance in a commanding position to further augment its market share.
Sally shared:” I am delighted to be part of PrimeVigilance’s continued success during this dynamic period of growth. I look forward to strengthening our client partnership in our endeavour to remain the leading pharmacovigilance service provider.”
Sally is always thinking about our customers and innovative solutions that will exceed their expectations today and in the future. This combination of a growth mindset and strength of leadership will help lead PrimeVigilance forward.
Please, join us in wishing Sally the very best in her new role!